Abstract
Regadenoson is a highly selective A2A receptor agonist and approved in many countries for myocardial perfusion pharmacological SPECT stress imaging. As a vasoactive drug, Regadenoson does have side effects, but there is only data regarding this issue available from some smaller studies, no
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
